Diabetes can result in retinopathy, which causes vision loss and blindness. Abnormalities of retinal vascular permeability precede the appearance of clinical retinopathy and could provide information about its pathogenesis. Increased retinal vascular permeability induced by retinal vascular disorders cause macular oedema [1] , which decreases visual acuity and is difficult to cure clinically. Abnormal retinal vascular permeability caused by the breakdown of the blood-retinal barrier (BRB) was found in patients with diabetes and animals with experimentally induced diabetes using vitreous fluorophotometry (VFP) [2±5].
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vascular permeability when administered intravitreally [6±8] . The expression of VEGF or its receptor was up-regulated in association with increased vascular permeability in the retina of streptozotocin-induced diabetes (STZ) rats [9, 10] . However, in the early stage of diabetes in rats, VEGF was not related to BRB breakdown [9] .
A recent study suggested that VEGF increases nitric oxide (NO) production in human vascular endothelium [11] . The proliferation or relaxation of endothelial cells by VEGF stimulation was reduced by inhibitors of NO synthesis, such as N-monomethyl-Larginine, N-nitro-L-arginine or N-nitro-L-arginine methyl ester [12, 13] . Calcium-dependent NO plays an important part in vascular permeability through cyclic guanosine monophosphate (GMP) [14] . The administration of NO increases retinal vascular permeability mediated through cyclic GMP increases [15] .
We hypothesized that increased retinal vascular permeability is correlated with the activation of endogenous constitutive NO synthase (NOS), such as neuronal NOS (nNOS) and endothelial NOS (eNOS). Their activity depends on increased calcium levels in rats with early STZ-induced diabetes. We thus evaluated retinal vascular permeability and the expression of retinal constitutive NOS in diabetic rats and control rats using VFP, in situ hybridization (ISH), semi-quantitative reverse transcription±poly-merase chain reaction (RT-PCR), immunohistochemistry (IHC), and Western blotting.
Materials and methods
Animal procedures. Male Wistar rats weighing 200±250 g were used for these experiments. All experiments involving animals were done in accordance with the principles of the Declaration of Helsinki. Diabetes in rats was induced with an intraperitoneal (i. p.) injection of 55 mg/kg of STZ (Sigma, St. Louis, Mo., USA) in 10 mmol/l citrate buffer (pH 4.5) after a 12-h fast. All rats with blood glucose concentrations greater than 250 mg/dl after 24 h were considered to have developed diabetes. All rats were studied 2 weeks after the STZ injection.
Retinal vascular permeability. Diabetes was induced in five rats and five other rats served as control subjects. After 2 weeks, body weight, blood glucose and retinal vascular permeability were measured in the diabetic and control rats. VFP measurements were done using a Fluorotron Master (Ocumetrics, Mountainview, Calif., USA) with a small animal adapter to determine retinal vascular permeability [16] . Rats were anaesthetized with pentobarbital (i. p. 0.3 mg/kg) 24 h before the VFP measurement and a polyvinyl catheter (inner diameter, 0.5 mm) implanted into the right jugular vein as previously described [17±20]. The catheter was positioned subcutaneously along the rat's shoulder and the distal end was exposed at the back of the neck. Each catheter was flushed with 0.1 ml of 1000 U sodium heparin before and after placement. After baseline VFP measurements were obtained, fluorescein-Na (Alcon, Fort Worth, Tex., USA) (2 mg/kg body weight) was injected into the catheters. VFP was measured 30 min after the injection. Vitreous fluorescein (VF) concentrations were calculated from 3 mm in front of the retinal peak on the scale of the small animal adapter. Blood samples were collected 5 and 35 min after injection and centrifuged at 1500´g for 10 min. The samples then were centrifuged in an ultrafiltration membrane cone (Millipore, Tokyo, Japan) at 2000´g for 15 min. The plasma unbound fluorescein (PUF) was measured using the Fluorotron Master with a plasma adapter [16] and the PUF curve of the time course was obtained. Retinal vascular permeability was calculated from the VF level and the PUF curve. Retinal vascular permeability (arbitrary units) was calculated as the difference between the VF level at 30 min and the VF level at base line divided by the area under the PUF curve at 0 to 30 min.
Section preparation. For section preparation, rats were killed using an overdose of pentobarbital and perfused with 4 % paraformaldehyde/0.1 mol/l phosphate buffer (PB). Their eyes were enucleated and post-fixed in the same solution at 4 C overnight. The eyes were then dehydrated and embedded in paraffin wax. Sections 7 mm thick were mounted on 3-aminopropyltriethoxysilane-coated slides. The sections were stored under dry conditions until histologic analysis. The histologic results shown are representative of six control rats and six diabetic rats.
In situ hybridization. All in situ hybridization was done according to a previously reported method with minor changes [21] . For probe synthesis, rat cDNA fragments for nNOS (Genbank X59949, nt4112±4585, 473 base pairs [bp]) and eNOS (Genbank U18336, nt1±189, 189 bp) were isolated using RT-PCR. These fragments were subcloned into pBluescript II KS + vector (Stratagene, Calif., USA). These templates were linearized, and digoxigenin (DIG)-labelled cRNA probes were prepared by in vitro transcription using T7 or T3 RNA polymerase (Roche, Tokyo, Japan). Forty nanograms of the probes were used for each slide.
Pre-hybridization procedures and hybridization were done for about 12 h at 58 C for each probe. After hybridization, the slides were washed and equilibration in Buffer 1 (100 mmol/l TRIS-HCl, pH 7.5 and 150 mmol/l NaCl) for 5 min. Blocking was done with 20 % sheep serum in Buffer 2 (Buffer 1 with 0.5 % skimmed milk and 0.1 % Tween 20) for 2 h at room temperature. The alkaline phosphatase-conjugated Fab fragments against DIG (diluted 1/2000 in 5 % sheep serum/Buffer 2, Roche) were incubated overnight at 4 C. For colourization, the slides were washed 30 min three times in Buffer 1, equilibrated in Buffer 3 (100 mmol/l TRIS-HCl (pH 9.5), 100 mmol/l NaCl and 50 mmol/l MgCl 2 ) for 10 min and stained with NBT/BCIP stock solution (Roche) in Buffer 3 at room temperature for about 12 h. The reaction was stopped with 10 mmol/l TRIS-HCl (pH7.6)/1 mmol/l EDTA, then the slides were mounted.
Semi-quantitative RT-PCR. The rats were killed as described previously. The eyes from the control rats and from the rats with diabetes for a duration of 2 weeks were immediately enucleated and the retinas were dissected from the scleral wall. The retinal total RNA was isolated using the AGPC method. The RNA extracted was quantitated by absorbance at 260 and 280 nm. Then 3 mg was used to synthesize cDNA by RT (SuperScript II, GIBCO BRL, Japan). PCR amplification was carried out with the following primers: CCTTCCGAAGCTT-CTGGCAACAGC (sense) and TGGACTCAGATCTAAG-GCGGTTGG (antisense) for nNOS (473 bp), TGCACCC-TTCCGGGGATTCTGGCA (sense) and GGATCCCTGG-AAAAGGCGGTCAGG (antisense) for eNOS (189 bp), and AAGTTCAATGGCACAGTCAAGGCT (sense) and GAG-GGTGCAGCGAACTTTATTGAT (antisense) for glyceraldehyde 3-phosphate dehydrogenase (GAPDH, 946 bp). The reaction was carried out for 23 to 30 cycles under the following conditions: denaturation, 95 C for 30 s; annealing, 60 C for 45 s; and extension, 72 C for 60 s. The PCR products were electrophoresed through 2 % agarose gel and photographed. The RT-PCR results shown represent those of three control rats and three diabetic rats.
Immunohistochemistry. The primary antibodies against eNOS and nNOS were purchased from Transduction Laboratories (Lexington, KY, USA). We carried out a specificity of these antibodies using preabsorbed antibody (biotin-conjugated goat anti-mouse Ig specific polyclonal antibody (multiple absorption), PharMingen, San Diego, Calif., USA) to confirm that immunoreactive staining did not occur. The sections were deparaffinized, rinsed in PBS, and treated with proteinase K (10 mg/ml) for 3 min. The sections were blocked in 20 % horse serum/PBS for 30 min at room temperature. These pretreated sections were incubated overnight at 4 C with monoclonal antibodies, nNOS and eNOS (diluted 1/1000 in PBS containing 0.5 % Triton-X100/3 % BSA/0.02 % Na-Azide). The sections then were rinsed in PBS, incubated for 2 h at room temperature with horse biotinylated anti-mouse IgG (diluted 1/500 in 20 % horse serum/PBS, Vector Laboratories, Calif., USA), rinsed again in PBS, and incubated in avidin/biotin-peroxidase complex (Vector Laboratories) for 1 h at room temperature. The sections then were rinsed in PBS and immersed in 0.05 mol/l TRIS-HCl (pH 7.6). Colourization was done in TRIS-HCl containing diaminobenzidine and hydrogen peroxide.
Retinal protein extraction and Western blotting. The retinal tissue was extracted as described previously. The total retinal protein was prepared according to a previously reported method [22] . The extracted tissue was solubilized in 3 % SDS buffer (1 mmol/l orthovanadium, 0.1 mg/ml phenyl methyl sulfonyl fluoride and 0.19 ml/ml aprotinin), and boiled for 10 min. The lysates were added to the same volume of 0.3 mol/l sucrose, homogenized and centrifuged at 14 000 rotations per minute for 15 min at 4 C. The lysates were stored at ±80 C until use.
For Western blotting, 50 mg total protein in SDS sample buffer was applied to each lane. The samples were electrophoresed onto 10 % SDS-polyacrylamide gels. After blotting, PVDF membranes were washed in TRIS-buffered saline containing 0.1 % Tween-20 (TBST) and incubated with primary antibodies (diluted: 1/3000) overnight at 4 C. The membrane was incubated with secondary antibody (sheep horseradish peroxidase linked anti-mouse Ig (Amersham, Tokyo, Japan), diluted 1/4000 in 5 % skim milk TBST) for 1 h at room temperature, and the ECL Western blot analysis system (Amersham) was used for detection. The Western blotting results shown represent four control rats and four diabetic rats. We also carried out an intensity analysis using NIH image.
Statistical analysis. Group comparisons were done using the unpaired Student's t-test with normal distributions and equal variance. Data was analysed using the Mann-Whitney rank sum test for populations with non-normal distributions or unequal variances. A p value of less than 0.05 was considered to be statistically significant.
Results
Retinal vascular permeability. Significant differences were found in blood glucose concentrations (108. (Fig. 1) .
Expression profile of nNOS and eNOS mRNA by in situ hybridization. We investigated nNOS and eNOS expression by ISH to determine if de novo synthesis occurred. In the control retinas, nNOS mRNA was expressed at a basal level in the inner nuclear layer (INL). Some strongly labelled cells were found in the innermost layer of the INL (Fig. 2A, arrow) . A few scattered positive cells were also detected in the ganglion cell layer (GCL), and were presumed to be displaced amacrine cells, as reported previously [23] . In the retinas of rats with diabetes of 2 weeks duration, nNOS expression increased in the INL and GCL cells (Fig. 2B) . A weak positive signal from eNOS in the control retina was detected at the basal level in the INL and GCL cells (Fig. 2D) . The eNOS expression also increased the number of expressing cells and the intensity of signal in the INL and GCL (Fig. 2E) . The sense probes for both NOSs did not demonstrate any positive retinal staining (Fig. 2C  and F) .
RT-PCR.
To confirm the ISH results, we carried out semi-quantitative RT-PCR (Fig. 3) . In the control retinas, the PCR product of nNOS was detectable but in Fig. 1 . Retinal vascular permeability in diabetic rats (n = 5) and control rats (n = 5) using vitreous fluorophotometry the diabetic retinas, the PCR products had undergone a great increase. A similar substantial increase of eNOS mRNA was observed in diabetic retinas. GAPDH, which served as an internal control, did not change in the PCR product in either control or diabetic rats. These results suggested that both NOS mRNA levels increased in the diabetic retina after STZ injection.
Expression profile of nNOS and eNOS protein by IHC. Because the expression levels of nNOS and eNOS mRNA were different in the control and diabetic retinas, we evaluated protein expression using IHC. In the control retinas, nNOS immunoreactivity (IR) was detectable in the cells of the INL and GCL (Fig. 4A) , although the number of positive cells was Fig. 2A, arrow) . In diabetic retinas, the expression of nNOS increased in the INL and GCL cells (Fig. 4B) . The nNOS IR in the cells located at the innermost layer of the INL was also stronger in the diabetic retina compared with control retinas. We observed nNOS-IR neurites with varicosity, which were probably arborying fibres from cells located in the INL and/or the GCL, in the inner prexiform layer (IPL). In the case of eNOS IHC, the IR was detected very weakly in the INL cells in control retinas (Fig. 4C) . However, strong IR was detected in the retinal vessels (Fig. 4C, arrowheads) . In diabetic retinas, eNOS IR increased in the cells of INL and GCL (Fig. 4D) . Vessel IR was relatively weak in diabetic retinas (Fig. 4D, arrowheads) .
Quantitative protein level by Western blot. After finding the expression of both NOSs was altered in diabetic retinas using IHC, we confirmed these increases by Western blotting (Fig. 5) . Both nNOS and eNOS were detected at 155 kDa and 140 kDa, respectively in the retinas from the control and the STZ-treated rats. After STZ injection, the expression levels of both NOSs increased. A densitometric analysis showed protein level of both NOSs were significantly increased in diabetic rats compared with the control rats.
Discussion
Abnormal retinal vascular permeability caused by BRB breakdown precedes the appearance of clinical diabetic retinopathy [2, 3] . Our study shows that retinal vascular permeability, as measured by VFP, increased significantly in the STZ-induced diabetic rats compared with control rats. This finding agrees with the results of previous studies in which retinal vascular permeability also increased at an early stage of experimentally-induced diabetes [4, 5, 15, 24] .
VEGF is a major vascular permeability factor [6, 7] and also increases retinal vascular permeability [8, 25] . The up-regulated expression of VEGF or its receptor was associated with increased vascular permeability in the retinas of STZ-induced diabetic rats [9, 10] . However, in the early stages of diabetes, VEGF is not up-regulated in the retina [9] . We found that VEGF expression in the diabetic retina 2 weeks after STZ injection, did not change (data not shown). Even though retinal vascular permeability precedes diabetic retinopathy [2, 3] , the concentration of VEGF in the vitreous does not increase in the early stages of diabetic retinopathy [26] suggesting that another factor induces increased retinal vascular permeability in the retina soon after the onset of diabetes.
Recent studies suggest that VEGF induces vascular dysfunction by NO and that VEGF increases vascular permeability by NOS [11±13, 27, 28] . Intravitreous administration of NO caused increased retinal vascular permeability in a dose-dependent manner [15] . NO could, therefore, play a crucial role in retinal vascular permeability in diabetes.
Endogenous NOS in the retina in experimentally induced diabetes is not well understood. Using histologic and quantitative analyses, we demonstrated that the expression of endogenous NOS increased in the diabetic retina. The localization of nNOS mRNA in the normal retina agreed with previous reports [23] . In the diabetic retina, the mRNA signal increased in the INL and GCL cells. From their distribution and previous reports, positive cells in the INL were assumed to be bipolar, horizontal, and amacrine cells, and in the GCL, displaced amacrine cells [23, 29] . Although cell species that express nNOS need to be identified, our results suggest that various neural types of retinal cells, except photoreceptor cells, increased nNOS mRNA. Our IHC results showed the presence of nNOS IR in the INL and GCL cells but not in the plexiform layer of the control retina. These results partially disagreed with the results of earlier studies [23, 30±34] which indicated that nNOS IR was detected in the INL and GCL cells [30, 31] . Some studies reported nNOS IR in the IPL [23, 31±34] but it was not observed [30] . The differences in these results might be because of the differences in using antibody or species. An undetected signal in our control IPL could be due to the low IR level because in diabetic retinas we observed strong IR in the IPL (Fig. 4B) . For amacrine cells, the number of NADPH-diaphorase-positive cells has been shown to decrease after STZ injection and the intensity of staining not to have changed in diabetic samples compared with control samples [35] . We did not count the number of nNOS-positive cells but the nNOS IR of amacrine cells was stronger in the diabetic retinas. A histologic examination therefore revealed several discrepancies requiring further investigation. In the central nervous system, nNOS is up-regulated during hypoxia [36, 37] . Retinal blood flow has been shown to decrease in diabetic rats, the same model as in our study [17±20] . The tissue generally became, however, hypoxic under diabetic conditions [38] . Hypoxia of the retinal tissue, not the specific cell type, could increase nNOS expression in the diabetic rats.
Our study found weak eNOS at the basal level in INL and GCL cells in control retinas and stronger eNOS in the diabetic retina using both ISH and IHC. In the human hippocampus, eNOS was expressed in the pyramidal neurons and astroglia-like cells [39] . We found that the major reaction appeared in the INL cells, which contained neuronal and glial cell bodies. We assumed the reactive cells to be mainly Muller cells [40] . In the vascular endothelium, the retina became hypoxic under the diabetic conditions described previously. However eNOS remains controversial because its expression increases or decreases in various types of endothelium cells under hypoxic conditions [41±48] . Furthermore, in the eNOS IHC retinal vessel IR seems to be weak in the diabetic retina while non-vessel IR increases. In a monkey subarachnoid haemorrhage model, eNOS increased in the cerebral cortex but decreased in the cerebral artery [49] , a phenomenon to our IHC results. One possible explanation for this discrepancy in the eNOS expression profile is that increased eNOS in non-vascular tissue could compensate for a decrease in the vessels. Although the amount of eNOS expression is altered in various tissues, the amount of eNOS increases in early diabetes, according to our quantitative results. Both retinal constitutive NOS expression level and retinal vascular permeability increased in diabetic retinas. Exogenous NO increases the retinal vascular permeability in rats [15] . Retinal blood flow decreased because of the activation of protein kinase C or endothelin-1 induced by high glucose concentrations in diabetes [19, 20] . Diabetic stress, including hypoxia, which is due to reduced retinal blood flow, could lead to increased free radical production in the retina and increase NOS. Thus, up-regulated constitutive NOS, which produces NO and is induced by diabetic stress, increases retinal vascular permeability in early diabetes. The retina, especially the INL, is composed of different types of cells, which vary in intricacy and in their forms of contact with other tissue. NO is produced by NOS from non-vascular tissue and has diffusible influences on retinal vessel and other tissue [50] . However, permeability could increase initially for some reason yet to be found, with a subsequent stimulation of the retinal tissue and expression of constitutive NOS.
In conclusion, increases in retinal vascular permeability can be found in the retina even in the early stages of diabetes. Constitutive NOS is also found to increase by histologic and quantitative analyses. Increased retinal vascular permeability could be associated with NOS up-regulation in the early stages of diabetic retinas suggesting that NOS is related to clinical vascular dysfunction in the early stages of diabetes. Abnormal production of NO could contribute to the development of diabetic retinopathy.
